Cargando…

Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis

Detalles Bibliográficos
Autores principales:	Issad, Belkacem, Ghali, Nasredine, Beaudreuil, Séverine, Griuncelli, Mireille, Cohen, Yves, Rostoker, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733676/ https://www.ncbi.nlm.nih.gov/pubmed/29270530 http://dx.doi.org/10.1016/j.ekir.2017.07.005

Ejemplares similares

Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
por: Rostoker, Guy, et al.
Publicado: (2018)

Re: Further Evidence Supporting the Accuracy of Quantitative Magnetic Resonance Imaging for Evaluating Iron Load in Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2017)

Histological Scores Validate the Accuracy of Hepatic Iron Load Measured by Signal Intensity Ratio and R2* Relaxometry MRI in Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2019)

Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2022)

Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study
por: Rostoker, Guy, et al.
Publicado: (2015)

Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients
por: Rostoker, Guy, et al.
Publicado: (2017)

Analysis of liver iron concentration in an elderly female undergoing hemodialysis with calcific uremic arteriolopathy does not support the role of iron overload in calciphylaxis: lesson for the clinical nephrologist
por: Rostoker, Guy, et al.
Publicado: (2021)

Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective
por: Rostoker, Guy, et al.
Publicado: (2021)

Maximal Standard Dose of Parenteral Iron for Hemodialysis Patients: An MRI-Based Decision Tree Learning Analysis
por: Rostoker, Guy, et al.
Publicado: (2014)

When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
por: Rostoker, Guy
Publicado: (2018)

Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies
por: Rostoker, Guy, et al.
Publicado: (2009)

Modulation of oxidative stress and microinflammatory status by colloids in refractory dialytic hypotension
por: Rostoker, Guy, et al.
Publicado: (2011)

Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century
por: Rostoker, Guy, et al.
Publicado: (2016)

A Case of Peritoneal Dialysis-related Peritonitis Caused by Aeromonas Hydrophila in the Patient Receiving Automated Peritoneal Dialysis
por: Kim, Hyun Jin, et al.
Publicado: (2018)

Factors Influencing the Choice of Automated Peritoneal Dialysis Treatment by Patients Receiving Home Peritoneal Dialysis
por: Cao, Fang, et al.
Publicado: (2023)

Successful treatment of Serratia Marcescens peritonitis in a patient receiving peritoneal dialysis
por: Yang, Ning, et al.
Publicado: (2020)

Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy
por: Taguchi, Kensei, et al.
Publicado: (2023)

A bibliometric analysis of the 100 most influential papers on peritoneal dialysis
por: Yuan, Xinke, et al.
Publicado: (2020)

Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations
por: Rostoker, Guy, et al.
Publicado: (2019)

Tuberculous peritonitis in a case receiving continuous ambulatory peritoneal dialysis(CAPD) treatment
por: Sahin, Garip, et al.
Publicado: (2004)

Serratia marcescens Peritonitis in a Diabetic Patient Receiving Continuous Ambulatory Peritoneal Dialysis
por: Kang, Ji Hyoun, et al.
Publicado: (2013)

Candida nivariensis, an emerging fungus causing peritonitis in a patient receiving peritoneal dialysis
por: Chamroensakchai, Tamonwan, et al.
Publicado: (2022)

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
por: Sarnak, Mark J, et al.
Publicado: (2023)

A Review on Major Pathways Leading to Peritoneal Fibrosis in Patients Receiving Continuous Peritoneal Dialysis
por: Taheri, Sogand, et al.
Publicado: (2022)

Stenotrophomonas Maltophilia Infection in Patients Receiving Continuous Ambulatory Peritoneal Dialysis
por: Baek, Joo-Eun, et al.
Publicado: (2004)

Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis
por: Zeng, Y., et al.
Publicado: (2016)

A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis
por: Wu, Hon-Yen, et al.
Publicado: (2016)

Effects of l-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis
por: Kuwasawa-Iwasaki, Masako, et al.
Publicado: (2020)

Impact of kidney size on mortality in diabetic patients receiving peritoneal dialysis
por: Chen, Chun-Hao, et al.
Publicado: (2021)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Correlation of Serum Asprosin Levels With Normalized Protein Catabolic Rate in Patients Receiving Peritoneal Dialysis Treatment
por: Koyuncu, Sümeyra, et al.
Publicado: (2023)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Peritoneal tuberculosis presenting as recurrent peritonitis secondary to treatment with intravesical Bacillus Calmette-Guérin in a patient receiving peritoneal dialysis
por: Iqbal, Junaid, et al.
Publicado: (2015)

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis
por: Nijstad, A. Laura, et al.
Publicado: (2020)

Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis
por: Manera, Karine E, et al.
Publicado: (2020)

Delivering Personalized, Goal-Directed Care to Older Patients Receiving Peritoneal Dialysis
por: Wu, Henry H.L., et al.
Publicado: (2023)

Diabetes Is the Most Critical Risk Factor of Adverse Complications After Peritoneal Dialysis Catheter Placement
por: Chang, Hsiao-Huang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ikl8uihr3alm893sk9gkol46oi